196 related articles for article (PubMed ID: 9601480)
1. Changes in intracellular Ca2+ mobilization and Ca2+ sensitization as mechanisms of action of physiological interventions and inotropic agents in intact myocardial cells.
Endoh M
Jpn Heart J; 1998 Jan; 39(1):1-44. PubMed ID: 9601480
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of SCH00013: a novel Ca2+ sensitizer.
Endoh M; Sugawara H; Mineshima M
Cardiovasc Drug Rev; 2001; 19(4):345-66. PubMed ID: 11830752
[TBL] [Abstract][Full Text] [Related]
3. Effects of a novel cardiotonic agent (+-)-6-[3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-quinolino ne (OPC-18790) on contractile force, cyclic AMP level, and aequorin light transients in dog ventricular myocardium.
Endoh M; Kawabata Y; Katano Y; Norota I
J Cardiovasc Pharmacol; 1994 May; 23(5):723-30. PubMed ID: 7521454
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Ca2+ signaling and Ca2+ sensitizers.
Endoh M
Circ J; 2008 Dec; 72(12):1915-25. PubMed ID: 18981594
[TBL] [Abstract][Full Text] [Related]
5. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M
J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
[TBL] [Abstract][Full Text] [Related]
6. The effects of various drugs on the myocardial inotropic response.
Endoh M
Gen Pharmacol; 1995 Jan; 26(1):1-31. PubMed ID: 7713348
[TBL] [Abstract][Full Text] [Related]
7. Effects of a novel cardiotonic agent, Org 9731, on force and aequorin light transients in intact ventricular myocardium of the dog: involvement of a cyclic AMP-mediated mechanism and myofibrillar responsiveness to Ca2+ ions.
Kawabata Y; Endoh M
J Card Fail; 1995 Mar; 1(2):143-53. PubMed ID: 9420644
[TBL] [Abstract][Full Text] [Related]
8. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.
Lues I; Beier N; Jonas R; Klockow M; Haeusler G
J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of Ca2+ sensitizers--update 2001.
Endoh M
Cardiovasc Drugs Ther; 2001 Sep; 15(5):397-403. PubMed ID: 11855658
[TBL] [Abstract][Full Text] [Related]
10. The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret.
Gwathmey JK; Morgan JP
Br J Pharmacol; 1985 May; 85(1):97-108. PubMed ID: 2992656
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.
Fujino K; Sperelakis N; Solaro RJ
Circ Res; 1988 Nov; 63(5):911-22. PubMed ID: 2846200
[TBL] [Abstract][Full Text] [Related]
12. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance.
Endoh M
Eur J Pharmacol; 2004 Oct; 500(1-3):73-86. PubMed ID: 15464022
[TBL] [Abstract][Full Text] [Related]
13. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
Böhm M; Morano I; Pieske B; Rüegg JC; Wankerl M; Zimmermann R; Erdmann E
Circ Res; 1991 Mar; 68(3):689-701. PubMed ID: 1660359
[TBL] [Abstract][Full Text] [Related]
14. Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension.
Haikala H; Levijoki J; Lindén IB
J Mol Cell Cardiol; 1995 Oct; 27(10):2155-65. PubMed ID: 8576932
[TBL] [Abstract][Full Text] [Related]
15. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.
Morgan JP; Erny RE; Allen PD; Grossman W; Gwathmey JK
Circulation; 1990 Feb; 81(2 Suppl):III21-32. PubMed ID: 2153479
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction and Ca2+ signaling in intact myocardium.
Endoh M
J Pharmacol Sci; 2006; 100(5):525-37. PubMed ID: 16799263
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations.
Shahid M; Martorana MG; Cottney JE; Marshall RJ
Br J Pharmacol; 1990 Aug; 100(4):735-42. PubMed ID: 2169938
[TBL] [Abstract][Full Text] [Related]
18. Influence of a Na+-H+ exchange inhibitor ethylisopropylamiloride, a Na+-Ca2+ exchange inhibitor KB-R7943 and their combination on the increases in contractility and Ca2+ transient induced by angiotensin II in isolated adult rabbit ventricular myocytes.
Fujita S; Endoh M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):575-84. PubMed ID: 10598797
[TBL] [Abstract][Full Text] [Related]
19. Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism.
Endoh M
Basic Res Cardiol; 1989; 84 Suppl 1():69-83. PubMed ID: 2554874
[TBL] [Abstract][Full Text] [Related]
20. Physiological and pathophysiological modulation of calcium signaling in myocardial cells.
Endoh M
Jpn Circ J; 1991 Nov; 55(11):1108-17. PubMed ID: 1660940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
